FORSTEO 250 µg/ml sol inj 250 µg 1 pce

7640458360238 CH-70481 H05AA02

No images available

Details

GTIN
7640458360238
Pharmacode
-
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/09/2026
Patient information leaflet
Français
05/09/2026
Patient information leaflet
Italien
05/09/2026
Professional SmPC
Allemand
05/09/2026
Professional SmPC
Français
05/09/2026
Professional SmPC
Italien
05/09/2026

Detailed composition

Substance Quantity Type Category
teriparatidum ADNr
250.0 UG Substance Wirkstoff (Principe actif)

Authorization holder

EurimPharm Swiss AG

9015 St. Gallen

Authorization information

Swissmedic authorization number
70481
Drug name
Forsteo, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
H05AA02
Authorization status
Z
Authorization category
Category P
Dispensation category
B
First authorization
06/02/2026
Authorization expiration date
05/02/2031
IT number
07.99.0.
Domain
Human medicine
Field of application
Postmenopausale Osteoporose bei Frauen; primäre und hypogonadale Osteoporose bei Männern. Glukokortikoid-induzierte Osteoporose bei Erwachsenen mit erhöhtem Frakturrisiko.

Packaging details

Description (FR)
FORSTEO 250 µg/ml sol inj 250 µg 1 pce
Description (DE)
FORSTEO 250 µg/ml Inj Lös 250 µg 1 Stk
Market launch
01/07/2026
Narcotic (BTM)
No

Available generics

Teriparatid-Mepha, Injektionslösung im Fertigpen
GTIN: 7680661020017
CHF 225.60
View
Buy us a coffee Explore the data